(Sharecast News) - Data science and biostatistics company Physiomics said on Monday that it had secured two new contracts with a UK-headquartered clinical-stage biopharmaceutical company.
Physiomics said the contracts, its first-ever biometrics awards, would see it aid the biopharmaceutical firm in developing immunotherapies that target a range of diseases.

In...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE